You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

tumor targeted gene therapy

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Tumor Cell Survival Following EGFR, ALK, ROS1 or BRAF TKI

Recruiting
  • Non-Small Cell Carcinoma of Lung, TNM Stage 4
  • +5 more
    • Aurora, Colorado
      University of Colorado, Cancer Center
    Nov 3, 2021

    Solid Tumor Trial in United States (NeoTCR-P1 adoptive cell therapy, nivolumab, IL-2)

    Suspended
    • Solid Tumor
    • NeoTCR-P1 adoptive cell therapy
    • +2 more
    • Duarte, California
    • +8 more
    Aug 16, 2022

    Results of Specific Gene Testing and Efficacy of Targeted

    Completed
    • Non Small Cell Lung Cancer
      • Changsha, Hunan, China
        Hunan Cancer hospital
      Mar 27, 2023

      HER-2 Gene Amplification, HER2-positive Gastric Cancer, HER2-positive Breast Cancer Trial in United States (chimeric antigen

      Recruiting
      • HER-2 Gene Amplification
      • +4 more
      • chimeric antigen receptor (CAR) T cell therapy
      • Duarte, California
      • +6 more
      Aug 10, 2022

      Advanced Malignant Solid Tumor Trial in United States (Adavosertib, Carboplatin, Everolimus)

      Completed
      Has Results
      • Advanced Malignant Solid Neoplasm
      • Aurora, Colorado
      • +7 more
      Apr 11, 2022

      Neuroendocrine Tumors, Neuroendocrine Tumor of the Lung, Neuroendocrine Tumor of Pancreas Trial in Iowa City, Rochester

      Not yet recruiting
      • Neuroendocrine Tumors
      • +8 more
      • Iowa City, Iowa
      • +1 more
      Nov 23, 2022

      Cutaneous Melanoma Trial in Paris (Blood sample, Cutaneous melanoma biopsy)

      Recruiting
      • Cutaneous Melanoma
      • Blood sample
      • Cutaneous melanoma biopsy
      • Paris, Ile De France, France
        Dermatology department
      Oct 24, 2022

      Early-stage Breast Cancer Trial in Heidelberg (Atezolizumab 1200 mg in 20 ML Injection, Inavolisib, Ipatasertib)

      Not yet recruiting
      • Early-stage Breast Cancer
      • Atezolizumab 1200 mg in 20 ML Injection
      • +5 more
      • Heidelberg, Baden-Wuerttemberg, Germany
        National Center for Tumor Diseases
      Sep 13, 2022

      Metastatic Clear Cell Renal Cell Carcinoma, With Positive PSMA Expression at Tumor Sites Trial (177Lu-PSMA-1

      Not yet recruiting
      • Metastatic Clear Cell Renal Cell Carcinoma
      • With Positive PSMA Expression at Tumor Sites
      • 177Lu-PSMA-1 (radiopharmaceutical)
      • (no location specified)
      Sep 26, 2023

      Nursing Caries, Gastrointestinal Stromal Tumors Trial in Nanjing (integrated care mode, conventional care mode)

      Recruiting
      • Nursing Caries
      • Gastrointestinal Stromal Tumors
      • integrated care mode
      • conventional care mode
      • Nanjing, Jiangsu, China
        Nanjing Drum Tower Hospital, The Affiliated Hospital of Nanjing
      Dec 17, 2022

      Cancer, Solid Tumor, Adult Trial in France (research of druggable molecular alterations on tumor biopsy)

      Active, not recruiting
      • Cancer
      • Solid Tumor, Adult
      • research of druggable molecular alterations on tumor biopsy
      • Bordeaux, France
      • +3 more
      May 16, 2022

      Soft Tissue Sarcoma, Bone Sarcoma Trial in Houston (Cyclophosphamide, attIL2-T cells)

      Not yet recruiting
      • Soft Tissue Sarcoma
      • Bone Sarcoma
      • Houston, Texas
        M D Anderson Cancer Center
      Nov 10, 2022

      Metastatic Solid Tumor, BRCA1 Mutation, BRCA2 Mutation Trial in San Francisco (Niraparib, Irinotecan)

      Not yet recruiting
      • Metastatic Solid Tumor
      • +4 more
      • San Francisco, California
        University of California, San Francisco
      Jan 12, 2023

      Semi-automated Segmentation Methods of SSTR PET for Dosimetry

      Not yet recruiting
      • Refractory Meningioma
      • To evaluate the SUVmean (Standard Uptake Value) as a predictive factor of the tumor absorbed dose compared to the SUVmax
      • (no location specified)
      Sep 8, 2022

      Severe Combined Immunodeficiency, X Linked, Gene Therapy Trial in United Kingdom, United States (autologous CD34+ cell

      Recruiting
      • Severe Combined Immunodeficiency, X Linked
      • Gene Therapy
      • autologous CD34+ cell transduced with G2SCID vector
      • Los Angeles, California
      • +4 more
      Jul 19, 2022

      Solid Tumor, Lung Cancer, Colorectal Cancer Trial in Chongqing (CEA CAR-T cells)

      Recruiting
      • Solid Tumor
      • +6 more
      • CEA CAR-T cells
      • Chongqing, Chongqing, China
      • +1 more
      Sep 9, 2022

      Immunotherapy Among BRAF-Positive Melanoma Patients Treated in

      Completed
      • Metastatic Melanoma
      • East Hanover, New Jersey
        Novartis Investigative Site
      Nov 11, 2022

      Peripheral Lung Tumor Trial (Padeliporfin Vascular Targeted Photodynamic (VTP) therapy)

      Not yet recruiting
      • Peripheral Lung Tumor
      • Padeliporfin Vascular Targeted Photodynamic (VTP) therapy
      • (no location specified)
      Jun 15, 2023

      Malignant Glioma of Brain, Astrocytoma, Malignant Astrocytoma Trial in Detroit (Ad5-yCD/mutTKSR39rep-ADP adenovirus and

      Recruiting
      • Malignant Glioma of Brain
      • +8 more
      • Ad5-yCD/mutTKSR39rep-ADP adenovirus and fractionated stereotactic radiosurgery (fSRS)
      • Detroit, Michigan
        Henry Ford Health System
      Jan 9, 2023

      Pediatric Cancer, CNS Tumor, Childhood, Skin Inflammation Trial in Boston (other, drug, behavioral)

      Recruiting
      • Pediatric Cancer
      • +2 more
      • Warm Baths or Showers
      • +5 more
      • Boston, Massachusetts
      • +1 more
      Jan 31, 2022

      TACE-HAIC Combined With TKIs and Immunotherapy Versus TACE Alone

      Completed
      • Hepatocellular Carcinoma
      • TACE-HAIC
      • +3 more
      • GuangZhou, Guangdong, China
        Sun Yat-sen University Cancer Center
      Sep 8, 2022

      Pancreas Cancer, CAR-T Cell Therapy, Mesothelin Trial in Guangzhou (CAR-T cells)

      Recruiting
      • Pancreas Cancer
      • +3 more
      • CAR-T cells
      • Guangzhou, Guangdong, China
        The Second Affiliated Hospital of Guangzhou Medical University
      Mar 10, 2023

      Metastatic Tumor, Renal Cell Carcinoma, Advanced Cancer Trial in Jinan (CD70 CAR-T cells)

      Recruiting
      • Metastatic Tumor
      • +2 more
      • CD70 CAR-T cells
      • Jinan, Shandong, China
        The Second People's Hospital of Shandong Province
      Jun 26, 2022

      Epithelial Ovarian, Fallopian Tube, Primary Peritoneal Cancer Trial in Houston (Paclitaxel/Bev (control), Paclitaxel/Bev + ZA

      Recruiting
      • Epithelial Ovarian
      • +2 more
      • Paclitaxel/Bev (control)
      • Paclitaxel/Bev + ZA (experimental)
      • Houston, Texas
        M D Anderson Cancer Center
      Aug 9, 2022

      Colorectal Cancer, Esophageal Cancer, Stomach Cancer Trial in Jinan (CEA CAR-T cells)

      Recruiting
      • Colorectal Cancer
      • +5 more
      • CEA CAR-T cells
      • Jinan, Shandong, China
        The Second People's Hospital of Shandong Province
      Jul 19, 2022